Swiss (SMI) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jan 13, 2026

Discover Swiss Pharmaceuticals & Biotech Growth Stocks that are on the SMI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
PPGN	CHF 28.85	12.3%	12.0%	CHF 988.1m	CHF 34.46	2.8	65.3%	0%
KURN	CHF 27.16	-1.7%	19.4%	CHF 1.1b	CHF 32.80	10.3	60.9%	n/a
COPN	CHF 107.20	-1.5%	65.2%	CHF 1.7b	CHF 98.03	30.5	35.2%	1.8%
SKAN	CHF 56.90	4.4%	-25.1%	CHF 1.2b	CHF 70.33	79.1	32.8%	0.7%
NWRN	CHF 26.75	-1.3%	193.3%	CHF 557.4m	CHF 37.44	22.7	31.2%	n/a
IDIA	CHF 3.82	2.8%	401.3%	CHF 939.0m	CHF 5.00	4.1	26.8%	n/a
GALD	CHF 161.60	-2.2%	44.5%	CHF 37.7b	CHF 166.24	126.7	26.5%	0.08%
SDZ	CHF 61.28	1.0%	52.9%	CHF 25.5b	CHF 56.25	145.2	25.7%	0.9%
LONN	CHF 558.00	1.5%	2.5%	CHF 39.4b	CHF 678.09	53.5	18.6%	0.7%
BANB	CHF 65.20	6.4%	14.7%	CHF 4.8b	CHF 73.39	36.4	15.5%	1.3%
TECN	CHF 154.60	11.4%	-32.1%	CHF 2.0b	CHF 193.79	31.1	13.1%	1.9%
ROG	CHF 344.10	1.7%	29.4%	CHF 291.0b	CHF 335.28	31.0	12.8%	2.8%
SFZN	CHF 85.80	8.6%	-11.1%	CHF 3.6b	CHF 108.67	24.4	10.6%	0.4%
NOVN	CHF 116.06	2.2%	28.1%	CHF 218.1b	CHF 110.02	19.3	7.7%	2.6%
MOLN	CHF 3.33	-2.1%	-34.7%	CHF 121.9m	CHF 9.00	1.3	-4.1%	n/a
BIOV	CHF 23.00	0.9%	n/a	CHF 132.7m	CHF 56.38	102.8	-14.8%	n/a
BSLN	CHF 56.60	5.6%	39.6%	CHF 664.8m	CHF 90.78	9.6	-22.6%	0%
SANN	CHF 13.26	8.3%	-5.3%	CHF 185.6m	CHF 30.00	3.6	48.7%	n/a
CURN	CHF 16.90	25.7%	17.0%	CHF 86.8m	CHF 98.10	n/a	n/a	n/a
XLS	CHF 25.20	-2.3%	-1.9%	CHF 145.9m	n/a	4.7	n/a	n/a
MMTX	CHF 1.46	-11.3%	n/a	CHF 233.8m	CHF 3.56	n/a	n/a	n/a
ADXN	CHF 0.056	10.2%	-11.0%	CHF 6.4m	n/a	41.5	n/a	n/a
DESN	CHF 364.50	-0.4%	73.2%	CHF 4.9b	CHF 460.00	41.6	n/a	0%

Page 1 of 1